Carcinogenesis mechanisms of Fusobacterium nucleatum

被引:125
|
作者
Gholizadeh, Pourya [1 ,2 ]
Eslami, Hosein [3 ]
Kafil, Hossein Samadi [4 ,5 ]
机构
[1] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[3] Tabriz Univ Med Sci, Dent & Periodontal Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Infect & Trop Med Res Ctr, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
关键词
Fusobacterium nucleatum; Mechanisms; Oral cavity cancer; Pancreatic cancer; Colorectal cancer; MELANOMA INHIBITORY-ACTIVITY; GINGIVAL EPITHELIAL-CELLS; MOBILITY GROUP BOX-1; TUMOR PROGRESSION; ORAL-CANCER; RECEPTOR; IMMUNE; ACTIVATION; INFECTION; FADA;
D O I
10.1016/j.biopha.2017.02.102
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Transformed cells of cancers may be related to stromal cells, immune cells, and some bacteria such as Fusobacterium nucleatum. This review aimed to evaluate carcinogenesis mechanisms of Fusobacterium spp. in the oral cavity, pancreatic and colorectal cancers. These cancers are the three of the ten most prevalence cancer in the worldwide. Recent findings demonstrated that F. nucleatum could be considered as the risk factor for these cancers. The most important carcinogenesis mechanisms of F. nucleatum are chronic infection, interaction of cell surface molecules of these bacteria with immune system and stromal cells, immune evasion and immune suppression. However, there are some uncertainty carcinogenesis mechanisms about these bacteria, but this review evaluates almost all the known mechanisms. Well-characterized virulence factors of F. nucleatum such as FadA, Fap2, LPS and cell wall extracts may act as effector molecules in the shift of normal epithelial cells to tumor cells. These molecules may provide new targets, drugs, and strategies for therapeutic intervention. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:918 / 925
页数:8
相关论文
共 50 条
  • [31] Septic arthritis due to Fusobacterium nucleatum
    Koornstra, JJ
    Veenendaal, D
    Bruyn, GAW
    de Graaf, H
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (11): : 1249 - 1249
  • [32] Endothelial Cell Response to Fusobacterium nucleatum
    Mendes, Reila Taina
    Nguyen, Daniel
    Stephens, Danielle
    Pamuk, Ferda
    Fernandes, Daniel
    Van Dyke, Thomas E.
    Kantarci, Alpdogan
    INFECTION AND IMMUNITY, 2016, 84 (07) : 2141 - 2148
  • [33] Fusobacterium nucleatum, the communication with colorectal cancer
    Luo, Kangjia
    Zhang, Yvkun
    Xv, Chao
    Ji, Jingjing
    Lou, Ge
    Guo, Xiaorong
    Chen, Meilun
    Zhang, Yingjie
    Wei, Huiying
    Guo, Mian
    Huang, Rui
    Yu, Shan
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 116
  • [34] Fusobacterium nucleatum and colorectal cancer:A review
    Fu-Mei Shang
    Hong-Li Liu
    World Journal of Gastrointestinal Oncology, 2018, (03) : 71 - 81
  • [35] THE METABOLIC VERSATILITY OF FUSOBACTERIUM-NUCLEATUM
    ROGERS, AH
    ZILM, PS
    CHEN, J
    JOURNAL OF DENTAL RESEARCH, 1995, 74 (03) : 766 - 766
  • [36] Coaggregation of Candida dubliniensis with Fusobacterium nucleatum
    Jabra-Rizk, MA
    Falkler, WA
    Merz, WG
    Kelley, JI
    Baqui, AAMA
    Meiller, TF
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) : 1464 - 1468
  • [37] Characterization of proteolytic activities of Fusobacterium nucleatum
    Ogawa, Alice Tayoko
    Campos Brasil de Souza, Tatiana de Arruda
    de Uzeda, Milton
    Jankevicius, Jose V.
    Jankevicius, Sbiduca Itow
    JOURNAL OF ENDODONTICS, 2006, 32 (06) : 521 - 523
  • [38] Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
    Caitlin A. Brennan
    Wendy S. Garrett
    Nature Reviews Microbiology, 2019, 17 : 156 - 166
  • [40] Fusobacterium nucleatum An emerging gut pathogen?
    Allen-Vercoe, Emma
    Strauss, Jaclyn
    Chadee, Kris
    GUT MICROBES, 2011, 2 (05) : 294 - 298